2015-2017 ACBS Child Combined Prevalence Tables
Table 7
Estimated percent using an inhaled corticosteroid in the past 3 months among children 1 with current 2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2015-2017.
State/Territory | Current | |||
---|---|---|---|---|
Sample size± |
% | SE§ | 95% CI† | |
California | 101 | 25.4 | 4.8 | (16.0 – 34.8) |
Connecticut | 152 | 31.0 | 5.0 | (21.2 – 40.8) |
Florida | 229 | 19.0 | 5.4 | (8.4 – 29.6) |
Georgia | 100 | 16.1 | 3.5 | (9.2 – 23.0) |
Hawaii | 82 | 24.7 | 6.1 | (12.7 – 36.7) |
Indiana | 124 | 31.3 | 6.3 | (19.0 – 43.6) |
Kansas | 245 | 38.4 | 3.9 | (30.8 – 46.0) |
Maine | 132 | 20.5 | 4.3 | (12.1 – 28.9) |
Michigan | 192 | 32.0 | 4.3 | (23.6 – 40.4) |
Minnesota | 228 | 29.4 | 4.1 | (21.4 – 37.4) |
Missouri | 68 | 29.4 | 7.9 | (13.9 – 44.9) |
Montana | 72 | 28.9 | 8.3 | (12.6 – 45.2) |
Nebraska | 197 | 33.9 | 5.4 | (23.3 – 44.5) |
New Jersey | 202 | 25.4 | 5.5 | (14.6 – 36.2) |
New Mexico | 105 | 40.9 | 7.2 | (26.8 – 55.0) |
New York | 95 | 25.0 | 6.1 | (13.0 – 37.0) |
Ohio | 157 | 14.3 | 3.5 | (7.4 – 21.2) |
Oregon | 68 | 39.0 | 8.0 | (23.3 – 54.7) |
Pennsylvania | 85 | 34.6 | 7.7 | (19.5 – 49.7) |
Rhode Island | 69 | 30.3 | 6.8 | (17.0 – 43.6) |
Utah | 191 | 34.1 | 4.6 | (25.1 – 43.1) |
Vermont | 81 | 36.5 | 7.0 | (22.8 – 50.2) |
Wisconsin | 42 | N/A | N/A | (N/A – N/A) |
Puerto Rico | 143 | 17.9 | 4.3 | (9.5 – 26.3) |
24 States / Area | 3,160 | 25.9 | 1.5 | (23.0 – 28.8) |
Median | 29.4 | |||
Range | 14.3-40.9 |
1 Aged < 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size is for multiple years of participation. Responses of “Don’t Know” and “Refused” are excluded.
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2017/pdf/sdq_report_acbs_17-508.pdfpdf iconpdf icon
Page last reviewed: February 16, 2021